Ardelyx Earlier Provided Update On 2024 Strategic Priorities; Expects FY24 U.S. Net Product Sales Revenue For IBSRELA To Be Between $140M-$150M; As Of December 31, 2023, The Co Had Total Cash, Cash Equivalents And Short-Term Investments Of ~$184M
Benzinga Newsdesk - Jan 8, 2024, 11:01AM